Fida Biosystems
Fida Biosystems is a Copenhagen-based life-science tools company that commercialises FIDA (Flow Induced Dispersion Analysis) technology — an in-solution biophysical characterisation platform — via the Fida Neo instrument, consumables, and software, serving pharmaceutical, biotech, CRO, and academic research customers including Novartis, Bayer, Moderna, and Genmab.
- Company typePrivate
- Founded2013
- HeadquartersCopenhagen, Denmark
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Fida Biosystems does
Fida Biosystems ApS is a Copenhagen-based life-science tools company that develops and commercialises FIDA (Flow Induced Dispersion Analysis), a first-principles, in-solution biophysical characterisation technology grounded in Taylor Dispersion Analysis and the Stokes-Einstein equation. The flagship Fida Neo instrument delivers more than ten biophysical readouts — including hydrodynamic radius, binding affinity (mM to pM), binding kinetics, aggregation, viscosity, stickiness, polydispersity index, and labelling quality — from a single assay in roughly one day, using as little as 40 nL of indicator and 4 µL of analyte. The platform covers a size range of 0.5 nm to 500 nm and is compatible with crude matrices (serum, plasma, fermentation media, cell lysate) without buffer, pH, or salt restrictions, differentiating it from surface-based techniques such as SPR.
The company sells its instruments, consumables (capillaries, coating solutions, 96-well plates via shop.fidabio.com), and FIDA Software Suite directly to pharmaceutical companies (Bayer, Novartis, GSK, Lilly, Sanofi, AstraZeneca, Novo Nordisk, Bristol-Myers Squibb, Merck, Eisai), biotechnology firms (Moderna, Genmab, Beam Therapeutics, Monte Rosa Therapeutics, Arbor Biotechnologies, C4 Therapeutics, Codiak Biosciences), CROs (Eurofins, Peak Proteins/Sygnature Discovery), and academic institutions (Rockefeller, University of Copenhagen, DTU, Karolinska, Francis Crick Institute). GTM is enterprise field sales with regional business developers, field application scientists, a "Pilot Your Samples" evaluation program, and discovery calls; post-sale enablement is delivered through bi-monthly training in Copenhagen, periodic training in Cambridge, MA, and a Motimate e-learning platform. In December 2025 the company closed a €5 million Series A led by Fåhraeus Startup and Growth with EIFO participation and announced a strategic partnership with Cytiva (a Danaher company) to broaden distribution and co-develop analytical capabilities.
Fida Biosystems firmographics
Firmographics- Name
- Fida Biosystems
- Legal name
- Fida Biosystems ApS
- Website
- https://fidabio.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Fida Biosystems is a Copenhagen-based life-science tools company that commercialises FIDA (Flow Induced Dispersion Analysis) technology — an in-solution biophysical characterisation platform — via the Fida Neo instrument, consumables, and software, serving pharmaceutical, biotech, CRO, and academic research customers including Novartis, Bayer, Moderna, and Genmab.
- Ownership category
- akta.pro rank
Fida Biosystems industry classification
Industry- Product category
- Biophysical Characterization Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Laboratory Quality & GLP/GCLP Compliance (HLAGAKAK)
Keywords
Where Fida Biosystems is headquartered
LocationHeadquarters
- HQ city
- Copenhagen
- HQ country
- Denmark
- HQ region
- Europe
Offices1 record
Markets served
Fida Biosystems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- FIDA Instruments: Sale of Fida Neo and Fida 1 instruments for biophysical analysis. The instruments enable molecular and nanoparticle characterization for drug discovery and research applications.
- Consumables: Capillaries, 96-well plates, coating solutions, and other consumables sold through the shop.fidabio.com webshop. Includes uncoated, dynamically coated, and permanently coated capillaries.
- Software License and Support: FIDA Software Suite included with instrument purchase. Optional 21 CFR Part 11 compliant version available. Service agreements with preventive maintenance offered.
- Training and Services: Advanced user training organized bi-monthly in Copenhagen, Denmark and periodically in Cambridge, Boston, USA. Field application scientist support and regional business developer assistance.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels9 records
Fida Biosystems product offering
Product offeringCore offering
Fida Biosystems manufactures and sells the Fida Neo instrument—an automated, in-solution biophysical characterization system—and the underlying FIDA (Flow Induced Dispersion Analysis) technology, which delivers over 10 readouts including molecular size, binding affinity, binding kinetics, aggregation, viscosity, stickiness, polydispersity, sample loss, and labelling quality from a single assay. The FIDA Software Suite accompanies the instrument, and recurring revenue comes from consumables (capillaries, plates, coating solutions), optional 21 CFR Part 11 compliant software, and advanced user training and service agreements.
Product overview
Fida Biosystems offers a unified product portfolio centered on FIDA (Flow Induced Dispersion Analysis) technology for biophysical characterization. The core offering consists of the Fida Neo instrument—a multiparameter in-solution analysis system—and the underlying FIDA Technology platform that delivers over 10 biophysical readouts including binding affinity, kinetics, molecular size, viscosity, aggregation, and polydispersity. The FIDA Software Suite provides assay design, instrument control, data analysis, and reporting capabilities. The company also operates a Consumables Webshop for purchasing capillaries and accessories. FIDA is used for applications including drug discovery, protein characterization, lipid nanoparticles, CRISPR, and bioprocessing research.
Differentiator
Problem solved
Functional benefit
Products and services
- Fida Neo Instrument A robust, automated instrument for fast, multiparameter in-solution biophysical analysis of molecules and nanoparticles, designed for pharmaceutical, biotech, academic, and CRO users performing protein characterization, binding studies, and quality control.
Quantifiable outcome
- 100+ instruments sold globally
- +6 more outcomes
Companies that use Fida Biosystems
Customer profileNamed customers27 records
Segments3 records
Ideal customer profiles3 records
Fida Biosystems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature10 records
Fida Biosystems partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CytivacoreDanaher company and life sciences industry leader collaborating with Fida Biosystems to expand analytical capabilities for protein research. The partnership aims to improve molecular insight for faster drug discovery.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Fida Biosystems competitors and assessment
Company assessmentBroad incumbents
- Cytiva (Biacore): Cytiva (Danaher) operates the Biacore SPR platform, the dominant surface-based biophysical characterization technology for protein-protein interaction, kinetics, and affinity — directly comparable to FIDA for the same pharma/biotech workflows. Cytiva is also Fida's strategic distribution partner, making it both competitor and channel.
- Malvern Panalytical: Malvern Panalytical (Spectris) offers Zetasizer, MicroCal (ITC/DSC), and other analytical instruments for particle size, zeta potential, and biomolecular stability — a broad biophysical characterization portfolio with overlapping pharma/biotech use cases to FIDA.
- Sartorius: Sartorius is a major bioprocessing and analytics vendor whose Incucyte, Octet (BLI), and biomolecular characterization tools address overlapping pharma/biopharma analytical workflows — especially in bioprocess QC and developability, where FIDA is also positioning via 21 CFR Part 11 software.
- Agilent Technologies: Agilent's Cell Analysis and Biopharma segments include Biacore (now Cytiva), Seahorse, and other analytical platforms used for protein interaction and biophysical characterization. Agilent is also a Fida customer logo, reflecting a partner-channel relationship alongside competitive overlap.
- Molecular Devices: Molecular Devices (Danaher) supplies high-content screening and analytical plate readers used in pharma drug discovery and biophysical assay workflows — a broader incumbent with partial overlap in protein and cell-based analytics used by FIDA's biopharma customers.
Direct peers
- Wyatt Technology: Wyatt Technology (acquired by Waters) provides multi-angle light scattering (MALS), dynamic light scattering, and field-flow fractionation instruments for absolute molecular weight, size, and aggregation analysis — overlapping strongly with FIDA's biophysical characterization readouts for proteins and nanoparticles.
- Nanotemper Technologies: Nanotemper provides Prometheus (nanoDSF), Monolith (MST), and Tycho instruments for protein stability, binding affinity, and thermal shift assays — a direct peer in label-free biophysical characterization of biologics, used in the same pharma/biopharma QC and developability workflows as FIDA.
- Unchained Labs: Unchained Labs sells biologics stability, formulation, and developability tools (e.g., Uncle, Stunner, Hunky) targeting protein formulation, AAV capsid stability, and LNP characterization — directly comparable to FIDA's biologics and gene therapy QC use cases.
Emerging players
- Refeyn: Refeyn commercializes mass photometry — an emerging single-molecule technique for mass measurement of biomolecules and native complexes — competing with FIDA's molecular size and aggregation readouts in protein and AAV analytics workflows.
Others
- Proteros: Proteros is a CRO providing protein crystallography and biophysical services (including Fida instruments as tools in their workflow) — comparable as a downstream service provider using biophysical characterization platforms for pharma drug discovery.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Fida Biosystems social profiles
Digital presenceFida Biosystems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fida Biosystems leadership team
Management profileNumber of profiles
Profiles4 records
Fida Biosystems funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fida Biosystems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fida Biosystems
What does Fida Biosystems do?
Fida Biosystems manufactures and sells the Fida Neo instrument—an automated, in-solution biophysical characterization system—and the underlying FIDA (Flow Induced Dispersion Analysis) technology, which delivers over 10 readouts including molecular size, binding affinity, binding kinetics, aggregation, viscosity, stickiness, polydispersity, sample loss, and labelling quality from a single assay. The FIDA Software Suite accompanies the instrument, and recurring revenue comes from consumables (capillaries, plates, coating solutions), optional 21 CFR Part 11 compliant software, and advanced user training and service agreements.
Is Fida Biosystems a public or private company?
Fida Biosystems is a private company. It is classified as venture growth investor backed and is currently operating.
When was Fida Biosystems founded?
Fida Biosystems was founded in 2013. It employs 1 to 10 people.
Where is Fida Biosystems based?
Fida Biosystems is headquartered in Copenhagen, Denmark, in the Europe region.
How does Fida Biosystems make money?
Four revenue lines are on record. FIDA Instruments are the primary driver. The others are consumables, software License and Support and training and Services.
Who are Fida Biosystems's main competitors?
Broad incumbents on record are Cytiva (Biacore), Malvern Panalytical, Sartorius, Agilent Technologies and Molecular Devices. Direct peers are Wyatt Technology, Nanotemper Technologies and Unchained Labs. Refeyn is listed as an emerging player. Proteros is listed as an others.
Does Fida Biosystems have an API?
No public API is recorded for Fida Biosystems.
What industry is Fida Biosystems in?
Fida Biosystems's product category is Biophysical Characterization Instruments. Its primary akta.pro industry code is HLAGAKAK, Laboratory Quality & GLP/GCLP Compliance. Its NAICS code is 334516 and its SIC code is 3826.